problems
The challenge for insurers
9.7m
People in Germany live with eye conditions, many go undetected until they’re severe.
56 days
Average wait for a specialist means delayed detection, higher claim costs, and poorer outcomes.
30%
Of patients are only treated once it’s too late, driving years of expensive, avoidable payouts.
Insurance insights
Why disruptive insurers choose Skleo
Preventive screenings are still rare in insurance, but the early movers already know:
-
Prevention pays
At the cost of less than one meal per insuree annually, screenings are far cheaper than long-term treatment that can cost thousands every quarter.
-
Easy to work with
Skleo fits into existing policies and processes. Insured members get screened for free at a Skleo partner site. Everything else, including reimbursement, happens quietly in the background between Skleo and the insurer.
-
Full patient-journey
From screening, to medical validation, to medical referral. Skleo guides your insurers through the entire patient journey if needed.
testimonials
What our partners
say about Skleo
-
Diabetic retinopathy was flagged during my screening. They directly assisted in organizing a specialist appointment, where it was confirmed.
This caught a disease that would have remained hidden until much further advanced.
I am relieved to be in treatment. -
As an ophthalmologist, I see patients struggling to secure timely appointments daily. Skleo is vital for securing long-term care. By combining AI with specialist validation, we identify exactly which patients urgently need specialized examinations.
